SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. on August 24, 2023. The report serves as a Regulation FD disclosure providing an update on the Company's technology team since its launch. The Company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain a financial statement or quarterly results.
Material Changes
The primary material event reported is the issuance of a press release (Exhibit 99.1) detailing progress regarding the Company's technology team. No financial comparisons to prior periods are included in this document.
Guidance, Outlook, and Risks
Management commentary is limited to the update on the technology team found in the attached press release. The filing explicitly states that the Company undertakes no obligation to update, supplement, or amend the materials provided. Furthermore, the Company notes that the information furnished is not intended to constitute a determination that the information is material or that dissemination is required under Regulation FD.
Key Facts for Investor Verification
- Verify the specific details of the technology team update by reviewing Exhibit 99.1 (Press Release dated August 24, 2023), as the 8-K body only references it.
- Confirm that no financial results or guidance were issued in this specific filing.
- Note the Company's disclaimer regarding the materiality of the disclosed information and the lack of obligation to provide future updates.
- Check the NASDAQ Capital Market status for the trading symbol BSGM.